Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Ryvu Therapeutics to Present Preclinical Data on Synthetic Lethality at the 2025 AACR Annual Meeting
Thursday, March 27, 2025Ryvu Therapeutics a clinicalstage drug discovery and development company focusing on novel therapies that address emerging targets in oncology today announced it will present preclinical data from its synthetic
Soleno Therapeutics Announces U.S. FDA Approval of VYKAT(TM) XR to Treat Hyperphagia in Prader-Willi Syndrome
Thursday, March 27, 2025Soleno Therapeutics Inc a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases today announced that the US Food and Drug Administration FDA has approved VYKAT XR diazoxide choline extendedrelease
Acumen Pharmaceuticals Completes Enrollment of ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
Thursday, March 27, 2025Acumen Pharmaceuticals Inc a clinicalstage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers AOs for the treatment of Alzheimers disease ADtoday announced the completion of enrollment in its ALTITUDE...
Xcellbio Announces Partnership with Planet Innovation to Develop and Manufacture Next Generation Instruments to Improve potency for Rapid Cell Therapy Manufacturing
Wednesday, March 26, 2025Xcell Biosciences Australia Pty Ltd an Australian affiliate of the San Franciscobased instrumentation company focused on cell and gene therapy applications has announced that it has entered into an agreement with the Royal Perth Hospital to use its A...
IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer
Tuesday, March 25, 2025IMUNON Inca clinicalstage company in Phase development with its DNAmediated immunotherapy today announced that the US Food and Drug Administration FDA is aligned with the protocol for the Phase pivotal trial called OVATION
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer
Monday, March 24, 2025CStone Pharmaceuticals a biopharmaceutical company dedicated to developing innovative cancer therapies today announced the submission of a Type II variation application to the European Medicines Agency EMA for sugemalimab
Registration Now Open for World Vaccine Congress Washington 2025: Leading Experts from Government, WHO, CEPI, and more to Speak.
Friday, March 21, 2025The World Vaccine Congress Washington the largest and most influential global vaccine event is officially open for registration Taking place from April at the Walter E Washington Convention Center the Congress will bring together thousands of glob...
Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
Friday, March 21, 2025Windtree Therapeutics Inc a biotechnology company focused on becoming a revenue generating biotech and advancing early and latestage innovative therapies for critical conditions and diseases is pleased to announce that it has entered into a License a...
Upperton Pharma Solutions Named Champion Award Winner in 2025 CDMO Leadership Awards
Friday, March 21, 2025Upperton Pharma Solutions a leading UKbased contract development and manufacturing organisation CDMO is proud to announce its recognition as the Champion Award Winner in the Small Molecule Dosage Form International category at the CDMO Leadership A...
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Thursday, March 20, 2025Servier an independent global pharmaceutical group governed by a nonprofit foundation and Black Diamond Therapeutics Inc Nasdaq BDTX a clinicalstage oncology company developing MasterKey therapies that target families of oncogenic mutations
